1. Home
  2. TDAY vs FBRX Comparison

TDAY vs FBRX Comparison

Compare TDAY & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TDAY

USA TODAY Co. Inc.

HOLD

Current Price

$7.06

Market Cap

1.1B

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$76.85

Market Cap

899.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDAY
FBRX
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
899.4M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
TDAY
FBRX
Price
$7.06
$76.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$9.00
$67.00
AVG Volume (30 Days)
2.3M
1.9M
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
105.56
61.30
EPS
0.18
N/A
Revenue
$1,526,024,000.00
$36,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.54
$10.18
52 Week High
$9.21
$77.20

Technical Indicators

Market Signals
Indicator
TDAY
FBRX
Relative Strength Index (RSI) 33.14 84.44
Support Level $6.52 $26.58
Resistance Level $7.48 $77.20
Average True Range (ATR) 0.49 0.17
MACD -0.20 -1.35
Stochastic Oscillator 18.27 50.00

Price Performance

Historical Comparison
TDAY
FBRX

About TDAY USA TODAY Co. Inc.

USA Today Co Inc is a diversified media company with national and local reach, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: